Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
about
Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumorsPhase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomasRecursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients.Brain tumors in the older person.Postoperative radiotherapy of astrocytomas.Medical therapy of gliomas.The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.Survival following adjuvant PCV or temozolomide for anaplastic astrocytomaThe role of chemotherapy in anaplastic astrocytoma patients.CNS Anticancer Drug Discovery and Development Conference White Paper.Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors.Chemotherapy for malignant glioma.Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma.The role of radiotherapy and chemotherapy in the treatment of primary adult high grade gliomas: assessment of patients for these treatment approaches and the common immediate side effects.Chemotherapy in the treatment of malignant gliomas.The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide.Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma.Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.Insights into pharmacotherapy of malignant glioma in adults.Radiation therapy and grade II/III oligodendroglial tumors.Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts.Penetration of intra-arterially administered vincristine in experimental brain tumor.Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma.NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.SEOM guideline for the treatment of malignant glioma.Nuclear Localization Signal-Enhanced Polyurethane-Short Branch Polyethylenimine-Mediated Delivery of Let-7a Inhibited Cancer Stem-Like Properties by Targeting the 3'-UTR of HMGA2 in Anaplastic Astrocytoma.
P2860
Q24683022-CF4A0D8E-EBA4-4968-8D8A-B203C77231DAQ30275188-34E44293-4AF1-439F-980B-9886897DB254Q33346613-34238B24-4B6A-4887-8006-6F7A2BC22868Q33375377-FE8897D5-8FD3-4D90-87A1-BF35EC99F901Q33519196-4ECECE50-BFBE-4B02-8FE1-26D1264CBB73Q33723390-40718336-40AF-4107-AD39-3C7C043EAD23Q34087862-DAA3A60F-6AB3-4F0A-B42D-E1A725A683C5Q34210447-9301114C-4534-4D41-A166-55F3CA919339Q34218761-98970218-5AD6-4376-A191-891F8EF2C6C7Q34498352-AB631D42-8099-4E6E-9992-0F414BB26F8DQ35800632-C1C1430E-292F-46C3-9534-9C146406D401Q36041149-B8A58680-151D-4176-B6D4-8A20D49CA5F3Q36089590-2B0FE9F9-7809-468B-85A7-9CAC54F70EEEQ36139736-F9389F0E-288A-4D46-A7EC-089159950D0CQ36307802-276E0FB0-A00E-4E63-9ED8-1783A8F0C6FCQ36462618-8CBCF910-2D76-4D51-A2E5-ACA239B74740Q36487745-5D441018-7DA0-4F60-9429-98193EEDF55BQ36499238-E7876AB8-944F-4714-9CF6-A1C7D123C944Q36676389-39B4F2BA-6B68-443C-BA98-B14977909CABQ36732622-C8B1185D-8AC7-4BF2-9A0B-F2CC0AE6109CQ37462007-D0AFEFD0-E660-4F06-A4F9-BC9CD310A6ADQ37575528-AB16C628-99E2-4B2F-9E41-547EB917E949Q38610442-053DEC9C-CC66-484A-9628-7CAEEFD3E372Q39417407-210C259D-8CED-4B9C-BA64-9935E983430FQ42243011-180CEF61-1238-4F2E-97B1-04A358C479B7Q46071407-41B8B0DB-196D-4CFF-ACF0-91233D1EF41CQ48100633-ECAEC40E-B258-4A82-94C0-BBB7D15E365BQ48464940-22369EB9-6978-4939-8C07-2AA518B1E766Q55460893-547BF60D-3583-41BB-B570-E91E15A47863
P2860
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Procarbazine, lomustine, and v ...... or PCV adjuvant chemotherapy.
@ast
Procarbazine, lomustine, and v ...... or PCV adjuvant chemotherapy.
@en
type
label
Procarbazine, lomustine, and v ...... or PCV adjuvant chemotherapy.
@ast
Procarbazine, lomustine, and v ...... or PCV adjuvant chemotherapy.
@en
prefLabel
Procarbazine, lomustine, and v ...... or PCV adjuvant chemotherapy.
@ast
Procarbazine, lomustine, and v ...... or PCV adjuvant chemotherapy.
@en
P2093
P1476
Procarbazine, lomustine, and v ...... or PCV adjuvant chemotherapy.
@en
P2093
P304
P356
10.1200/JCO.1999.17.11.3389
P407
P577
1999-11-01T00:00:00Z